US 11672762
Onapristone extended-release compositions and methods
granted A61KA61K31/575A61K9/20
Quick answer
US patent 11672762 (Onapristone extended-release compositions and methods) held by CONTEXT BIOPHARMA, INC. expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CONTEXT BIOPHARMA, INC.
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/575, A61K9/20, A61K9/2054, A61P